Source: Annual Congress 2012 - Diffuse parenchymal lung disease II



Rating:

Share or cite this content

Citations should be made in the following way:
J. Videnovic-Ivanov, S. Filipovic, V. Vucinic, V. Zugic (Belgrade, Republic Of Montenegro). Obstructive findings in sarcoidosis, diagnosis and therapies modalities. Eur Respir J 2012; 40: Suppl. 56, 3637

Member's Comments

No comment yet.

Related content which might interest you: Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management Source: Eur Respir J 2016; 47: 45-68 Year: 2016 Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management Source: Guideline 2016 Year: 2016 Improvement of diagnosis and treatment of obstructive lung diseases with a one stop diagnostic consultancy Source: Annual Congress 2006 - COPD – the challenges for primary care Year: 2006 Evaluation of fatigue state with virus-related novel biomarkers in obstructive lung diseases Source: International Congress 2016 – Notable abstracts on clinical problems related to asthma Year: 2016 Treatment of COPD by clinical phenotypes: putting old evidence into clinical practice Source: Eur Respir J 2013; 41: 1252-1256 Year: 2013 Emerging anti-inflammatory strategies for COPD}, Source: Eur Respir J 2012; 40: 724-741 Year: 2012 Clinical outcomes of patients with idiopathic pulmonary fibrosis in clinical practice: Follow-up results of the INSIGHTS-IPF registry Source: International Congress 2015 – IPF: clinical aspects II Year: 2015 Disease entities and microbiological results of 430 patients with non-CF bronchiectasis - Target for new diagnostics and therapies? Source: International Congress 2016 – Clinical and microbiological aspects of bronchiectasis and non-tuberculous mycobacterium (NTM) infections Year: 2016 Chronic obstructive pulmonary disease: phenotyping and differential diagnosis Source: International Congress 2018 – Imaging Grand Round Year: 2018 Comparison of spirometry criteria for the diagnosis of COPD: results from the BOLD study Source: Eur Respir J 2009; 34: 588 Year: 2009 Recommendations of the ATS/ERS Task Force for the definition of outcomes for COPD pharmacological trials Source: Annual Congress 2006 - Outcomes for COPD pharmacological trials: from lung function to biomarkers Year: 2006 Guidelines versus clinical practice in the treatment of chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: 903-908 Year: 2001 Heart rhythm disorders in patients with chronic obstructive pulmonary disease Source: International Congress 2016 – Exploring mechanisms in health and disease Year: 2016 Chronic obstructive pulmonary disease (COPD) patients with bronchiectasis: clinical features? Source: International Congress 2018 – COPD exacerbations and bronchiectasis Year: 2018 Thoracic high resolution computed tomography may be helpful in the differentiation between the patients with chronic obstructive pulmonary disease and the smoking patients with asthma Source: Annual Congress 2013 –Asthma at the bedside Year: 2013 Clinical consequences of late Chronic Obstructive Pulmonary Disease (COPD) diagnosis compared to early diagnosis in UK primary care Source: International Congress 2019 – COPD treatment: cohorts and real-world studies Year: 2019 Use of clinical characteristics to predict spirometric classification of obstructive lung disease Source: International Congress 2016 – Phenotyping and monitoring airway diseases Year: 2016 Investigation of KL-6 levels in patients with IPF- OSA overlap syndrome: Preliminary results Source: International Congress 2016 – ILD: from the bench to the bedside Year: 2016 Clinical features of chronic obstructive pulmonary disease in never smokers Source: International Congress 2016 – Phenotyping and monitoring airway diseases Year: 2016 A functional and radiological multiparametric approach to the study of parenchymal features of chronic obstructive pulmonary disease Source: Annual Congress 2012 - Standard of care, incidential findings, image acquisition Year: 2012